Questions and Answers: Beta-Blockers for Acute Myocardial Infarction


How are heart failure patients with AMI handled in the CMS/JCAHO beta-blocker measures?


In the 'Beta Blocker on Arrival' measure (AMI-6), patients with documented heart failure on arrival or within 24 hours of arrival are automatically excluded from the measure, regardless of whether they received a beta blocker, via any route. Terminology considered synonymous with heart failure is extensive (see 'Contraindication to Beta Blocker on Arrival' definition for more details):

Please note that chest x-ray reports are excluded sources in data collection—but MD/NP/PA references to chest x-ray findings are acceptable.

AMI patients with heart failure are not automatically excluded from the Beta Blocker at Discharge measure (AMI-5). If an MD/NP/PA documents that he/she did not prescribe beta blockers at discharge because of the patient's heart failure, the case will be excluded.


Will the CMS/JCAHO measure be changed as a result of the findings from the COMMIT/CCS-2 study?


We are aware of this study and CMS, JCAHO, ACC, AHA and AHRQ are working together to address these findings. For details, go to the CMS, JCAHO, ACC, AHA and AHRQ Practice Advisory.

American College of Cardiology Foundation
American Health Association
Agency for Healthcare Research and Quality
Centers for Medicare & Medicaid Services
Joint Commission of Healthcare Organizations

April 2005

Internet Citation:

Questions and Answers: Beta-Blockers for Acute Myocardial Infarction. April 27, 2005. Agency for Healthcare Research and Quality, Rockville, MD.

Return to Outcomes & Effectiveness
AHRQ Home Page
Department of Health and Human Services